Rebirth: Super Banking System Chapter 2347 - 2187: A Pair of Jokers

~4 minute read · 1,056 words
Previously on Rebirth: Super Banking System...
A week into his stay at the Myanmar medical center, Shi Ze awoke feeling invigorated by the experimental treatments for cognitive disorders, noting marked improvements in his own sleep and mental clarity. Patients around him showed rapid progress in the first treatment phase, with enhanced perception and memory stirring hope among families, while the cost-effective therapy—around 100,000 Asia Dollars—drew international attention and urgent demands for global rollout. In the special care ward, a late-stage patient, nearly vegetative upon arrival, began recognizing loved ones and uttering simple words after twelve days, as constant family stimulation aided recovery. Shi Ze, assisting with rounds among dozens of severe cases, marveled at the drugs' efficacy, particularly the versatile Transcription Fluid, and yearned to bring the breakthrough to his homeland.

United States.

Seattle.

In the president's office at the headquarters of a major pharmaceutical corporation.

"How's it going?"

"Tough."

"Not even for cash?"

"Yeah."

"..."

The president fell silent, cursing inwardly—when did these politicians get so principled, aside from the ones they back, stepping up to assist.

Hardly any outsiders managed to pull it off.

Blast it!

Where were the greedy lawmakers of old? This week, they'd contacted plenty, but the outcomes were dismal, and he struggled to swallow it.

Bribing with funds.

Lobbying efforts.

Hosting lavish dinners.

All fell flat.

"Why?" The president massaged his weary eyes.

Sitting opposite.

Bitterness etched the man's features.

"They claim it clashes with American priorities; one misstep and global backlash hits hard. You know our President's drive for health reforms."

"And?"

"They're stuck too, preferring to hold off and observe."

At those words.

The president's mouth quirked in frustration.

Fine.

He'd half-anticipated this; normally, hitting foreign firms wouldn't touch U.S. benefits, yet here, it's akin to the Transcription Fluid saga.

Should it face scrutiny.

The real victims wouldn't be Myanmar Pharmaceutical Group, but U.S. officials—Alzheimer's alone could drain trillions extra from public coffers.

Plus other burdens.

On top of that.

Innumerable sufferers would rebel; if it escalates, protests erupt everywhere.

Hence.

Shoving this forward proves nearly impossible.

Pounding head.

Aching chest.

Body in full torment.

Vast fortunes escape their grasp yearly, and they're loath to let go; with the mess already unfolding, quashing it exceeds their power.

"Whew!"

The president exhaled heavily.

Darn it.

If only they'd foreseen.

They ought to have rushed the Transcription Fluid to market earlier, bargaining with rivals to bury this medication—it'd turned into them hemorrhaging funds instead.

"Now what?" the aide inquired.

President: "..."

Tough luck.

Beats me.

Standard influence tactics failing signals the end of leaning on U.S. powers to crush the foe outright.

Currently.

Self-reliance is all that's left.

Yet.

Another frustrating hurdle looms: how to proceed? Crowds are already rushing to Myanmar for cures, outcomes dazzle and buzz will spread like wildfire.

Barring U.S. intervention.

They.

Remain mere a business entity—how to halt such momentum? If Huaxia opts to adopt it, dare they meddle? It's an illness.

The fatal sort.

Thus.

Even amid chaos, even if success hovers at fifty percent or death lurks, throngs of desperate patients will swarm for any shot at survival.

Against dying.

Desperation.

Outweighs demise itself.

Earlier.

They'd schemed to spread bad press, but it flopped; waves of skepticism vanished under floods of outrage—America's spirit rebels against the establishment, after all.

The louder the noise.

The fiercer the backlash.

The shakier corporate credibility. Films portray it clear: schemers, baddies... often top brass or tycoons.

So.

When rival pharma firms voiced dangers, public fury swallowed them whole, echoing the Transcription Fluid frenzy, where madness trumped death in the public's eye.

Risks, you say?

Blast it!

Tell it to your ancestor.

Scram!

If you've got the skills, whip up a working remedy; otherwise, zip it.

As a result.

Every big pharma outfit clammed up, avoiding personal statements to dodge the mob's wrath—patient fury is a beast.

For minor ailments.

Slam them.

And move on.

However.

Life-or-death stakes turn smears into boomerangs; even paid experts saw their residences vandalized repeatedly.

It's brutal!

All aspects.

Prove utterly frustrating.

Influence peddling.

Fails to budge.

Opinion shaping.

Turns chaotic.

The alliance.

Lurks in silence, leaving him sensing total isolation, right then a call came through, twisting his expression.

Moments later.

He sighed deeply.

"What's up?"

"That DuPont heir with Alzheimer's, stuck in bed for three years? He's on a flight now, bound for Myanmar treatment."

"..."

The alliance.

Can't be trusted anymore.

Past.

This clan backed them on Transcription Fluid matters, but now, for this remedy at least, a key ally slips away.

What's more.

A crucial pillar, since it's not solo—they've got networks too, broadcasting a clear warning: back off this medicine.

"Ha!"

"You've triumphed!"

Either way, he's tapped out.

...

Over the Pacific.

A Boeing jet soars amid clouds, opulently fitted like a personal aircraft, boasting two levels and an expansive sickbay.

Right now.

A crowd gathers nearby.

"Father's voice hasn't rung in ages." By the bedside, a sixty-year-old gazed fondly at the dozing nonagenarian.

This journey.

Aware that late-stage recovery remains possible, consequences be damned—life comes first; truth be told, it's not unlinked to politics, practical angles factor in too.

This situation.

With consortium buy-in, pushing ahead would be straightforward.

But.

Splits inside arose, rendering moves against Myanmar a nightmare, endless checks, plus advisors' reports deeming assaults on Myanmar Pharmaceutical Group pointless toil.

Thus.

They shrug it off.

Ahead.

Time stretches on—tackle urgents now; anyway, fresh gossip lately softened his grudge against Myanmar.

As it happens.

These wonders tie back to the Ford clan.

No surprise.

All this while, on Myanmar matters, Fords favored growth, viewing it as a lamb to shear once plump.

Odd indeed.

For one.

Slaughter methods? Unspecified.

For two.

Why not reclaim and fatten it themselves? Same result, right?

On that.

Ford spun tales galore, even tossing in: greater mysteries, greater thrills. Such drivel muddled the Myanmar debate.

Leaving him perpetually baffled.

Today.

It clicks—this lamb was Ford-nurtured, though it later bolted; kin ties convinced Ford they'd reclaim it.

So.

Learning this shifted the elder's view of Myanmar instantly; foe's lamb or not, sharing's feasible, prolonging its nurture isn't awful.

Once matured.

And plump.

Devouring it might taste even better.

Besides.

It doubles as sly tactics, particularly with tightening Huaxia bonds and pacts—should they feast on this plump lamb someday.

It turns into leverage.

Haha.

Clever.

The deeper the thought.

The more intriguing it grows, clarifying puzzles like Myanmar's wealth hoarding without arming up, taunting: if you can, strike me.

No regard for U.S. dignity.

CIA.

Repeatedly shamed there.

Thrashed.

Tormented.

He'd puzzled over their boldness against CIA, but now it dawns: they're 'family'! This epiphany amused the elder greatly.

Grasping Ford's 'fun' at last.

Reflecting.

It's downright delightful.